BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 7499324)

  • 1. Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes.
    Gether U; Lin S; Kobilka BK
    J Biol Chem; 1995 Nov; 270(47):28268-75. PubMed ID: 7499324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the beta 2 adrenergic receptor mapped by site-selective fluorescent labeling.
    Jensen AD; Guarnieri F; Rasmussen SG; Asmar F; Ballesteros JA; Gether U
    J Biol Chem; 2001 Mar; 276(12):9279-90. PubMed ID: 11118431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of ligand-induced conformational changes in the beta2 adrenergic receptor.
    Kobilka B; Gether U; Seifert R; Lin S; Ghanouni P
    Life Sci; 1998; 62(17-18):1509-12. PubMed ID: 9585127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of ligand-induced conformational changes in the beta 2-adrenergic receptor by fluorescence spectroscopy.
    Kobilka BK; Gether U
    Adv Pharmacol; 1998; 42():470-3. PubMed ID: 9327941
    [No Abstract]   [Full Text] [Related]  

  • 5. Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility.
    Gether U; Ballesteros JA; Seifert R; Sanders-Bush E; Weinstein H; Kobilka BK
    J Biol Chem; 1997 Jan; 272(5):2587-90. PubMed ID: 9006889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor.
    Gether U; Lin S; Ghanouni P; Ballesteros JA; Weinstein H; Kobilka BK
    EMBO J; 1997 Nov; 16(22):6737-47. PubMed ID: 9362488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescent labeling of the leukocyte NADPH oxidase subunit p47(phox): evidence for amphiphile-induced conformational changes.
    Park HS; Park JW
    Arch Biochem Biophys; 1998 Dec; 360(2):165-72. PubMed ID: 9851827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of ligand-induced conformational states in the beta 2 adrenergic receptor.
    Kobilka B; Gether U; Seifert R; Lin S; Ghanouni P
    J Recept Signal Transduct Res; 1999; 19(1-4):293-300. PubMed ID: 10071765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific fluorescence labeling of the beta2 adrenergic receptor amino terminus.
    Parola AL; Lin S; Kobilka BK
    Anal Biochem; 1997 Dec; 254(1):88-95. PubMed ID: 9398350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor.
    Ghanouni P; Steenhuis JJ; Farrens DL; Kobilka BK
    Proc Natl Acad Sci U S A; 2001 May; 98(11):5997-6002. PubMed ID: 11353823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential signaling of the endogenous agonists at the beta2-adrenergic receptor.
    Reiner S; Ambrosio M; Hoffmann C; Lohse MJ
    J Biol Chem; 2010 Nov; 285(46):36188-98. PubMed ID: 20837485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor.
    Ghanouni P; Gryczynski Z; Steenhuis JJ; Lee TW; Farrens DL; Lakowicz JR; Kobilka BK
    J Biol Chem; 2001 Jul; 276(27):24433-6. PubMed ID: 11320077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist-induced conformational changes in the beta2 adrenergic receptor.
    Kobilka BK
    J Pept Res; 2002 Dec; 60(6):317-21. PubMed ID: 12464109
    [No Abstract]   [Full Text] [Related]  

  • 14. Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor.
    Chidiac P; Nouet S; Bouvier M
    Mol Pharmacol; 1996 Sep; 50(3):662-9. PubMed ID: 8794908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor.
    Yao X; Parnot C; Deupi X; Ratnala VR; Swaminath G; Farrens D; Kobilka B
    Nat Chem Biol; 2006 Aug; 2(8):417-22. PubMed ID: 16799554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FRET-based monitoring of conformational change of the beta2 adrenergic receptor in living cells.
    Nakanishi J; Takarada T; Yunoki S; Kikuchi Y; Maeda M
    Biochem Biophys Res Commun; 2006 May; 343(4):1191-6. PubMed ID: 16580633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of guanine, inosine, and xanthine nucleotides on beta(2)-adrenergic receptor/G(s) interactions: evidence for multiple receptor conformations.
    Mol Pharmacol; ; . PubMed ID: 10419554
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.